In particular, a significant reduction in RTE (CD4+CD31+) T cells, together with increased CM and CD4+CD28− cells, especially the CD4+CD28−CD57+ and CD4+CD45RA+CCR7−CD28− cells, were the main characteristics of stage III/IV LN patients’ immune phenotype. This evidence concerns the gene CD28 and lobular neoplasia.